We validated the expression pattern and biological functions of FCGR2A through IHC and in vitro assays, demonstrating its significant upregulation in HCC tissues and its capacity to promote tumor cell proliferation, migration, and invasion. The gene discussed is FCGR2A; the disease is neoplasm.